000			02010nas a22003255i 4500
001			1437-7772
003			DE-He213
005			20260610082524.0
007			cr nn 008mamaa
008			150723s||||||||si uu poo|||||| b|EN |d
022			_a1437-7772
024	7		_a10.1007/10147.1437-7772 _2doi
210	1	0	_aInt J Clin Oncol
245	1	0	_aInternational Journal of Clinical Oncology _h[electronic resource] / _cedited by Noriomi Matsumura, Masaki Mandai.
264		1	_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer.
300			_bonline resource.
520			_aThe International Journal of Clinical Oncology (IJCO) welcomes original and review papers on all aspects of clinical oncology that report the results of novel and timely investigations. Reports on clinical trials are encouraged. Priority is given to high-quality clinical articles, including prospective randomized studies, rather than retrospective studies. Basic and translational studies will only be accepted if they have obvious clinical significance. Membership in the Japan Society of Clinical Oncology is not a prerequisite for submission to the journal. Papers are received on the understanding that their content has not been published in whole or in part elsewhere; that they are subject to peer review by at least two referees and the Editors, and to editorial revision of the language and contents; and that the Editors are responsible for their acceptance, rejection, and order of publication.
650		0	_aOncology.
650		0	_aCancer—Treatment.
650		0	_aCancer.
650	1	4	_aOncology.
650	2	4	_aCancer Therapy.
650	2	4	_aCancer Biology.
700	1		_aMatsumura, Noriomi. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aMandai, Masaki. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service)
776	0	8	_iPrinted version: _x1341-9625
856	4	0	_uhttps://doi.org/10.1007/10147.1437-7772 _zHybrid
999			_c3774 _d3774